Back

Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Statins, bempedoic acid and ezetimibe: novel findings Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Negin Soroush

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice
Professor F. Schiele (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial
Associate Professor S. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021
Doctor G. Tan (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Statins, bempedoic acid and ezetimibe: novel findings

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources